Related Experiment Video

Updated: Aug 19, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

Silencing of CXCR4 blocks breast cancer metastasis

Zhongxing Liang1, Younghyoun Yoon, John Votaw

  • 1Department of Hematology/Oncology, Winship Cancer Institute, Emory University, 1701 Uppergate Drive, Atlanta, GA 30322, USA.

Cancer Research
|February 12, 2005
PubMed

Insights

Directly injecting small interfering RNA (siRNA) duplexes into an animal model prevents tumor formation, offering a new strategy for cancer prevention and treatment. This RNA interference approach specifically targets and blocks CXCR4, inhibiting breast cancer metastasis.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Gene Silencing Technology

Background:

  • RNA interference (RNAi) is a key technology for gene function studies in mammalian cells.
  • Cancer metastasis remains a significant challenge in oncology, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To investigate the potential of small interfering RNA (siRNA) duplexes as a preventive and therapeutic strategy for cancer.
  • To evaluate the efficacy of targeting CXCR4 using siRNA in inhibiting breast cancer metastasis in an animal model.

Main Methods:

  • Direct injection of a pool of naked siRNA duplexes into an animal model.
  • Utilizing siRNA targeting CXCR4 to block gene expression at the mRNA level.
  • Assessing breast cancer cell invasion using Matrigel invasion assays and in vivo metastasis models.

Main Results:

  • Direct siRNA injection prevented tumorigenesis in a cancer model.
  • Blocking CXCR4 expression with a combination of two siRNAs impaired breast cancer cell invasion.
  • Inhibition of breast cancer metastasis was observed in the animal model.

Conclusions:

  • Direct siRNA delivery represents a novel preventive and therapeutic approach for cancer management.
  • Targeting CXCR4 is crucial for inhibiting breast cancer metastasis.
  • Using multiple siRNAs against a single gene may enhance efficacy by overcoming functional redundancy.

More Related Videos

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer07:35

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...